Arrowhead Pharmaceuticals Inc (ARWR)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -299,413 | -205,002 | -180,502 | -150,708 | -157,320 | -178,507 | -159,560 | -118,519 | -188,304 | -149,037 | -134,273 | -118,351 | -112,359 | -93,158 | -33,401 | 1,141 | 45,392 | 61,191 | 40,384 | 5,868 |
| Total assets | US$ in thousands | 626,286 | 765,552 | 795,856 | 891,308 | 891,489 | 691,939 | 751,782 | 703,575 | 638,539 | 710,148 | 734,927 | 756,795 | 499,251 | 522,504 | 555,728 | 561,076 | 587,602 | 349,845 | 336,828 | 333,940 |
| Operating ROA | -47.81% | -26.78% | -22.68% | -16.91% | -17.65% | -25.80% | -21.22% | -16.85% | -29.49% | -20.99% | -18.27% | -15.64% | -22.51% | -17.83% | -6.01% | 0.20% | 7.72% | 17.49% | 11.99% | 1.76% |
December 31, 2023 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-299,413K ÷ $626,286K
= -47.81%
Arrowhead Pharmaceuticals Inc.'s operating return on assets (operating ROA) has been fluctuating over the past eight quarters. The operating ROA ranged from -47.81% in Q1 2024 to -16.85% in Q2 2022. Overall, the operating ROA has generally been negative, indicating that the company's operating income generated from its assets has been insufficient to cover its asset base during this period. The negative trend suggests that Arrowhead Pharmaceuticals Inc. may be facing challenges in effectively utilizing its assets to generate operating profits. Further analysis and closer monitoring of the company's operational efficiency and asset management practices may be necessary to improve its operating ROA in the future.
Peer comparison
Dec 31, 2023